Richard Aplenc, MD, PhD, MSCE
Richard Aplenc, MD, PhD, MSCE
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
CTRB Room 4018
3501 Civic Center Blvd
Philadelphia, PA 19104
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: 2674267252
Email:
aplenc@email.chop.edu
aplenc@email.chop.edu
Education:
A.B. (Classics)
Princeton University, 1988.
University of Pennsylvania, Post-Baccalaureate Pre-Health Program, 1989.
MD
University of Virginia, 1994.
MSCE (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2002.
PhD (Epidemiology)
University of Pennsylvania, 2011.
Permanent linkA.B. (Classics)
Princeton University, 1988.
University of Pennsylvania, Post-Baccalaureate Pre-Health Program, 1989.
MD
University of Virginia, 1994.
MSCE (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2002.
PhD (Epidemiology)
University of Pennsylvania, 2011.
Selected Publications
Puumala S. E., Ross J. A., Aplenc R., Spector L. G.: Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer 60(5): 728-33, May 2013.Walker D. M., Fisher B. T., Seif A. E., Huang Y. S., Torp K., Li Y., Aplenc R.: Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: Analysis of a national cohort of patients in the pediatric health information systems database. Pediatr Blood Cancer 60(4): 616-20, Apr 2013.
de Blank P., Zaoutis T., Fisher B. T., Troxel A., Kim J., Aplenc R.: Trends in Clostridium difficile Infection and Risk Factors for Hospital Acquisition of Clostridium difficile among Children with Cancer. The Journal of pediatrics Page: [Epub ahead of print] Mar 2013.
Grupp S. A., Kalos M., Barrett D., Aplenc R., Porter D. L., Rheingold S. R., Teachey D. T., Levine B. L., June C. H.: Induction of Complete Remissions of ALL by Chimeric Antigen Receptor-expressing T Cells. N Engl J Med Page: [Epub ahead of print] March 2013.
Kavcic M., Fisher B.T., Torp K., Li Y., Huang Y.S., Seif A.E., Vujkovic M., Aplenc R.: Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database. Pediatr Blood Cancer 60(3): 508-11, Mar 2013.
Diamond J. M., Lee J. C., Kawut S. M., Shah R. J., Localio A. R., Bellamy S. L., Lederer D. J., Cantu E., Kohl B. A., Lama V. N., Bhorade S. M., Crespo M., Demissie E., Sonett J., Wille K., Orens J., Shah A. S., Weinacker A., Arcasoy S., Shah P. D., Wilkes D. S., Ware L. B., Palmer S. M., Christie J. D.; Lung Transplant Outcomes Group.: Clinical risk factors for primary graft dysfunction after lung transplantation. American journal of respiratory and critical care medicine 187(5): 527-34, Mar 2013.
Sung L., Aplenc R., Alonzo T. A., Gerbing R. B., Lehrnbecher T., Gamis A. S.: Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group. Blood Page: [Epub ahead of print] Mar 2013.
Kavcic M., Fisher B. T., Li Y., Seif A., Torp K., Walker D. M., Huang Y. S., Lee G. H., Tasian S. K., Vujkovic M., Bagatell R., Aplenc R.: Induction Mortality and Resource Utilization in Children Treated for Acute Myeloid Leukemia at Free-Standing Pediatric Hospitals in the United States. Cancer Page: [Epub ahead of print] Feb 2013.
Meyer N.J., Feng R., Li M., Zhao Y., Sheu C.C., Tejera P., Gallop R., Bellamy S., Rushefski M., Lanken P. N., Aplenc R., O'Keefe G. E., Wurfel M. M., Christiani D. C., Christie J. D.: IL1RN Coding Variant Is Associated with Lower Risk of Acute Respiratory Distress Syndrome and Increased Plasma IL1RA. American journal of respiratory and critical care medicine Page: [Epub ahead of print] Feb 2013.
Gupta V., Richards S., Rowe J.; Acute Leukemia Stem Cell Transplantation Trialists' Collaborative Group.: Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis. Blood 121(2): 339-50, Jan 2013.